The National Cancer Institute (NCI) is exploring capabilities and interest in the marketplace for a potential future contract related to brand name or equal laboratory equipment. Specifically, they seek information on businesses that can supply a BMG Labtech VANTAstar-F Plate Reader or an equivalent solution. This is a sources sought notice, indicating that no solicitation is currently available, but responses will help determine the most appropriate acquisition method.
The NCI aims to identify small businesses that can meet their requirements for this specialized equipment used in measuring and controlling devices. Interested parties are invited to respond with a maximum 10-page written submission, clearly detailing their ability to fulfill the NCI's needs. The information sought in the responses will assist in deciding the acquisition approach and whether a small business set-aside is feasible.
Any submitted information must be non-proprietary, as the NCI reserves the right to use it in future solicitations. Responses are due by 10:00 A.M. EST on Monday, July 29, 2024, and should be sent to the contract specialist whose contact details are provided in the attached document.
This is a competitive process, and businesses should expect a high level of competition for this potential opportunity. The NCI is under no obligation to issue a contract or respond to submissions. However, if a requirement formalizes, a solicitation may be published, with responses to this notice given precedence for a small business set-aside consideration.
For any clarifications or questions, interested parties may contact John Russell or Reyes Rodriguez, whose email addresses are provided in the notice.